Home / Companies / Blueprint Medicines Corporation / 18 Jun 2025
Blueprint Medicines Corporation: meeting of 18 Jun 2025
Votes reported on Form N-PX, item by item
548 Form N-PX filers reported votes at the Blueprint Medicines Corporation meeting of 18 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 67.9% of reported votes for; 91 filers withheld from or voted against at least one nominee.
1,283 vote records from 216 filers. 71 of the 216 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
842 vote records from 545 filers. 45 of the 527 filers that marked the item either way voted against management. 18 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
429 vote records from 216 filers. 2 of the 216 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | For | No report |
| State Street and SPDR | For | For | For |
| American Century | Abstain or withhold * | Against * | For |
| Franklin Templeton | For | For | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | Abstain or withhold * | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | For | For | For |
| WisdomTree | Abstain or withhold * | For | For |
| PGIM and Prudential | For | For | For |
| Jackson National funds | For | For | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Abstain or withhold | For | For |
| Voya | For | For | For |
| First Trust | Abstain or withhold * | For | For |
| Russell Investments | For | For | For |
| Nationwide | For | For | For |
| Victory Capital | Abstain or withhold * | For | For |
| Brighthouse Funds | For | For | For |
| Guggenheim and Rydex | Abstain or withhold * | For | For |
| Columbia Threadneedle | For | For | For |
| BNY Mellon | Abstain or withhold * | For | For |
| Principal | Abstain or withhold * | For | For |
| Capital Group and American Funds | For | For | For |
| Pacific Life funds | Abstain or withhold * | For | For |
| Global X | For | For | For |
| MFS | Abstain or withhold * | For | For |
| Transamerica | For | For | For |
| AllianceBernstein | For | For | For |
| Hartford Funds | For | For | For |
| DWS | Abstain or withhold * | For | For |
| PIMCO | No report | For | No report |
| Allspring | Abstain or withhold * | For | For |
| MassMutual | For | For | For |
| Macquarie and Delaware Funds | Abstain or withhold * | For | For |
| Janus Henderson | No report | For | No report |
| Neuberger Berman | For | For | For |
| Natixis and Loomis Sayles | No report | For | No report |
| Lord Abbett | For | For | For |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Blueprint Medicines Corporation meeting?
548 Form N-PX filers reported votes at the meeting of 18 Jun 2025. On say-on-pay, 45 of 527 voted against management (8.5%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Blueprint Medicines Corporation on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Blueprint Medicines Corporation
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Blueprint Medicines Corporation with a meeting date within three days of 18 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.